VITASPRING BIOMEDICAL CO., LTD. Capital Expenditures
VITASPRING BIOMEDICAL CO., LTD. (VSBC) reported Capital Expenditures of $0 for the 12-month period ending 2023-01-31, per its 10-K filed 2025-12-01.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2025-12-01
- VITASPRING BIOMEDICAL CO., LTD. payments to acquire property, plant, and equipment for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- VITASPRING BIOMEDICAL CO., LTD. payments to acquire property, plant, and equipment for fiscal 2022 was $73.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|
| 2023-01-31 | $0.00 10-K · filed 2025-12-01 |
| 2022-01-31 | $73.00K 10-K · filed 2025-12-01 |